Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Comparative analysis of proteolysis in human cell lines during apoptosis and cell differentiation

FY 2011-12

Summary
The human genome encodes for about 600 enzymes called proteases. These important proteins are involved in a diverse number of biological processes - some function as non-specific degrading enzymes associated with protein catabolism, while others act as very specific enzymes degrading only certain protein substrates. For example, apoptosis, or programmed cell death, is an important example of a biological process that is regulated by limited and specific intracellular proteolysis, predominantly carried out by the caspase family of proteases. Moreover, these important proteins also regulate cell differentiation, a process by which human cells are transformed into mature forms in order to carry out their specific functions. Malfunctions of the cell differentiation mechanism can lead to various forms of cancer and leukemia. Since many chemotherapeutics kill cells by inducing apoptosis, understanding this process is highly relevant from a therapeutic standpoint in order to fight the propagation of cancer cells. The proposed work aims to characterize, at a molecular level, how different types of cancer cells respond to different types of drugs, contributing to a better understanding of apoptosis that may be influential in the development of novel drugs and therapeutic regimens for cancer. Furthermore, the comparison and extent of cleavage substrates by caspases between cells undergoing apoptosis in comparison to cells undergoing differentiation will bring insights into the balance of cellular life and death at the molecular level. Thus, in addition to mapping the process of apoptosis and cell differentiation, the proposed work may identify new drug targets for the development of therapies. Finding new therapeutics is of great importance in our fight against cancer, since this devastating disease remains one of the leading causes of death.
Program
CIHR Fellowship
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
242745
Name
Julien Olivier
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Comparative analysis of proteolysis in human cell lines during apoptosis and cell differentiation
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Apoptosis; Cancer; Caspases; Cell Differentiation; Chemotherapeutic; Degradomics; Human Cell Lines; Protein Engineering; Proteolysis; Proteomics
Abstract
The human genome encodes for about 600 enzymes called proteases. These important proteins are involved in a diverse number of biological processes - some function as non-specific degrading enzymes associated with protein catabolism, while others act as very specific enzymes degrading only certain protein substrates. For example, apoptosis, or programmed cell death, is an important example of a biological process that is regulated by limited and specific intracellular proteolysis, predominantly carried out by the caspase family of proteases. Moreover, these important proteins also regulate cell differentiation, a process by which human cells are transformed into mature forms in order to carry out their specific functions. Malfunctions of the cell differentiation mechanism can lead to various forms of cancer and leukemia. Since many chemotherapeutics kill cells by inducing apoptosis, understanding this process is highly relevant from a therapeutic standpoint in order to fight the propagation of cancer cells. The proposed work aims to characterize, at a molecular level, how different types of cancer cells respond to different types of drugs, contributing to a better understanding of apoptosis that may be influential in the development of novel drugs and therapeutic regimens for cancer. Furthermore, the comparison and extent of cleavage substrates by caspases between cells undergoing apoptosis in comparison to cells undergoing differentiation will bring insights into the balance of cellular life and death at the molecular level. Thus, in addition to mapping the process of apoptosis and cell differentiation, the proposed work may identify new drug targets for the development of therapies. Finding new therapeutics is of great importance in our fight against cancer, since this devastating disease remains one of the leading causes of death.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Julien, Olivier
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~